/Prof. Patrick Gunning
Patrick Gunning Outlines his Quest to Find New Cancer Treatments by Developing Small Molecule STAT Inhibitors
Patrick Gunning Outlines his Quest to Find New Cancer Treatments by Developing Small Molecule STAT Inhibitors
10 Jun 2017

Professor Patrick Gunning discusses his work developing small molecule inhibitors for STAT proteins, with the aim of developing new cancer treatments. STAT-3 is found to be hyperactive in over 70% of human cancer, leading to uncontrolled cell growth, whilst STAT-5 has recently been identified as a target in haematological oncology.

This video won the Drug Discovery & Development Video Interview of the Year in the 2018 Scientists' Choice Awards. Find out more about the awards here

Related Scientists

Related Content